PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086228
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1086228
Dermatophytic Onychomycosis Treatment Market, By Product Type (TabletsMail Paints), By Treatment, By End User, and by Regions - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Nail onychomycosis is a fungal infection is caused by a trichophyton rubrum, trichophyton mentagrophytes, and in some cases it is caused by yeasts and molds. The major factors responsible for nail onchomycosis infection is increased exposure to worm and moist environment which leads to perfect condition for fungus to grow and proliferate. The major symptoms of onychomycosis comprises of white and yellow spots under the nail leading to discoloration, nail thickening, and formation of crumbling edges on the nail.
Key features of the study:
- This report provides in-depth analysis of the global dermatophytic onychomycosis treatment market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global dermatophytic onychomycosis treatment market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include Valeant Pharmaceuticals International Inc., Galderma S.A., Novartis AG, Pfizer Inc., Moberg Pharma AB, Janssen Global Services, LLC (Johnson & Johnson Services, Inc.), Anacor Pharmaceuticals, Inc., NovaQuest Capital Management, L.L.C., and Novan, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global dermatophytic onychomycosis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global dermatophytic onychomycosis treatment market
Detailed Segmentation:
- Dermatophytic Onychomycosis Treatment Market, By Product Type:
- Tablets
? Rx
? OTC
- Mail Paints
? Rx
? OTC
- Dermatophytic Onychomycosis Treatment Market, By Treatment:
- Oral
- Topical
- Dermatophytic Onychomycosis Treatment Market, By End User:
- Hospitals
- Clinics
- Independent Pharmacies
- Mail Order Pharmacies
- Drug Stores
- Dermatophytic Onychomycosis Treatment Market, By Region:
- North America
? By Product Type:
? Tablets
? Rx
? OTC
? Mail Paints
? Rx
? OTC
? By Treatment
? Oral
? Topical
? By End User
? Hospitals
? Clinics
? Independent Pharmacies
? Mail Order Pharmacies
? Drug Stores
? By Country:
? U.S.
? Canada
- Latin America
? By Product Type:
? Tablets
? Rx
? OTC
? Mail Paints
? Rx
? OTC
? By Treatment
? Oral
? Topical
? By End User
? Hospitals
? Clinics
? Independent Pharmacies
? Mail Order Pharmacies
? Drug Stores
? By Country:
? Brazil
? Mexico
? Argentina
? Rest of Latin America
- Europe
? By Product Type:
? Tablets
? Rx
? OTC
? Mail Paints
? Rx
? OTC
? By Treatment
? Oral
? Topical
? By End User
? Hospitals
? Clinics
? Independent Pharmacies
? Mail Order Pharmacies
? Drug Stores
? By Country:
? Germany
? U.K.
? France
? Italy
? Spain
? Russia
? Rest of Europe
- Asia Pacific
? By Product Type:
? Tablets
? Rx
? OTC
? Mail Paints
? Rx
? OTC
? By Treatment
? Oral
? Topical
? By End User
? Hospitals
? Clinics
? Independent Pharmacies
? Mail Order Pharmacies
? Drug Stores
? By Country:
? China
? India
? Japan
? Australia
? South Korea
? ASEAN
? Rest of Asia Pacific
- Middle East
? By Product Type:
? Tablets
? Rx
? OTC
? Mail Paints
? Rx
? OTC
? By Treatment
? Oral
? Topical
? By End User
? Hospitals
? Clinics
? Independent Pharmacies
? Mail Order Pharmacies
? Drug Stores
? By Country:
? GCC
? Israel
? Rest of Middle East
- Africa
? By Product Type:
? Tablets
? Rx
? OTC
? Mail Paints
? Rx
? OTC
? By Treatment
? Oral
? Topical
? By End User
? Hospitals
? Clinics
? Independent Pharmacies
? Mail Order Pharmacies
? Drug Stores
? By Country:
? South Africa
? Central Africa
? North Africa
- Company Profiles
- Valeant Pharmaceuticals International Inc. *
? Company Overview
? Product Portfolio
? Key Highlights
? Financial Overview
? Strategies
- Galderma S.A.
- Novartis AG
- Pfizer Inc.
- Moberg Pharma AB
- Janssen Global Services, LLC (Johnson & Johnson Services, Inc.)
- Anacor Pharmaceuticals, Inc.
- NovaQuest Capital Management, L.L.C.
- Novan, Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Therapy Type
- Market Devices, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- New Product Launches
- Mergers and Acquisitions
- Regulatory Scenario
- Reimbursement Scenario
- PEST Analysis
- Pipeline Analysis
4. Global Dermatophytic Onychomycosis Treatment Market, By Therapy Type, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Systemic Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Topical Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Device-based Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
5. Global Dermatophytic Onychomycosis Treatment Market, By End User, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Dermatology Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
6. Global Dermatophytic Onychomycosis Treatment Market, By Region, 2017 - 2028, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- North America
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Therapy Type, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Million)
- Market Size and Forecast, By Country, 2017 - 2030, (US$ Million)
- South Africa
- Central Africa
- North Africa
7. Competitive Landscape
- Market Share Analysis
- Company Profiles
- Bausch Health Companies*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Galderma SA
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Celtic Pharma
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Anacor pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Novartis AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Topica Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- GlaxoSmithKline
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Future Plans
- Analyst Views
8. Section
- References
- Research Methodology
- About us and Sales Contact
